Get the Stockscreener App
220.65
1.08%
2.35
After Hours:
220.65
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cme Group Inc stock is traded at $220.65, with a volume of 1.75M.
It is up +1.08% in the last 24 hours and up +2.28% over the past month.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
See More
Previous Close:
$218.30
Open:
$219
24h Volume:
1.75M
Relative Volume:
0.85
Market Cap:
$79.03B
Revenue:
$5.80B
Net Income/Loss:
$3.30B
P/E Ratio:
26.33
EPS:
8.38
Net Cash Flow:
$3.49B
1W Performance:
+2.22%
1M Performance:
+2.28%
6M Performance:
+2.49%
1Y Performance:
+10.20%
1-Day Range:
$217.23
$221.36
1-Week Range:
$213.97
$221.36
52-Week Range:
$190.70
$223.80
Cme Group Inc Stock (CME) Company Profile
Name
Cme Group Inc
Sector
Phone
(312) 930-1000
Address
20 S. WACKER DR., CHICAGO, IL
Cme Group Inc Stock (CME) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-03-24 | Downgrade | Goldman | Neutral → Sell |
| Sep-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-28-23 | Initiated | Barclays | Overweight |
| Jan-05-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-12-22 | Initiated | Citigroup | Buy |
| Oct-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-17-22 | Initiated | Rosenblatt | Sell |
| Aug-15-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-10-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| May-25-22 | Upgrade | Oppenheimer | Perform → Outperform |
| May-16-22 | Downgrade | Argus | Buy → Hold |
| Feb-15-22 | Initiated | Credit Suisse | Neutral |
| Feb-10-22 | Reiterated | BofA Securities | Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Compass Point | Neutral |
| Feb-10-22 | Reiterated | Deutsche Bank | Hold |
| Feb-10-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jan-20-22 | Upgrade | Rosenblatt | Sell → Neutral |
| Dec-16-21 | Initiated | BofA Securities | Underperform |
| Sep-14-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jun-25-21 | Resumed | Credit Suisse | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-30-21 | Downgrade | Argus | Buy → Hold |
| Mar-24-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-01-21 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
| Feb-25-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-15-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Sep-11-20 | Initiated | Loop Capital | Sell |
| Apr-14-20 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-26-20 | Upgrade | UBS | Neutral → Buy |
| Jan-10-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-16-19 | Initiated | Credit Suisse | Neutral |
| Sep-19-19 | Downgrade | Berenberg | Buy → Hold |
| Sep-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-18-19 | Downgrade | Rosenblatt | Neutral → Sell |
| Feb-15-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-11-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Dec-04-18 | Resumed | Barclays | Overweight |
| Nov-28-18 | Initiated | Atlantic Equities | Neutral |
| Nov-28-18 | Downgrade | UBS | Buy → Neutral |
| Nov-20-18 | Upgrade | Berenberg | Hold → Buy |
| Nov-20-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | BofA/Merrill | Buy |
| Jul-10-18 | Initiated | Compass Point | Neutral |
| Apr-10-18 | Initiated | Bernstein | Outperform |
View All
Cme Group Inc Stock (CME) Latest News
CME Group to Expand Battery Metals Suite with Launch of Spodumene Futures on October 28 - Batteries News
CME expands lithium futures battle with LME as battery demand soars - Financial Times
CME Group to Expand Battery Metals Suite with Launch of Spodumene Futures on October 28 - CME Group
CME Group to Expand Battery Metals Suite with Launch of Spodumene Futures on October 28 - Lelezard
New Lithium Contracts Added to CME Bourse as Appetite Soars - Yahoo Finance
CME Group to Expand Battery Metals Suite with Launch of Spodumene Futures on October 28 - StockTitan
Aviso Wealth Management Purchases 5,540 Shares of CME Group Inc. (NASDAQ:CME) - MarketBeat
LME lags rival exchanges as battery metals trading gains momentum - Marketscreener.com
MBB Public Markets I LLC Makes New $5.14 Million Investment in CME Group Inc. (NASDAQ:CME) - MarketBeat
The Market Is Pricing in Another 200 Basis Points of Rate Cuts by the End of 2025. Is That Too Much? - The Motley Fool
U.S. Treasury Bond Futures Overview - CME Group
Canadian Dollar CAD/USD Overview - CME Group
Euro FX EUR/USD Futures Overview - CME Group
CME Group director William R. Shepard buys $63,945 in stock By Investing.com - Investing.com Australia
Soybean Futures Overview - CME Group
Live Cattle Futures Overview - CME Group
Nasdaq, ICE get Outperform ratings at RBC in new exchange coverage (NASDAQ:CME) - Seeking Alpha
Learn to Evaluate (CME) using the Charts - Stock Traders Daily
CME Group (NASDAQ:CME) Coverage Initiated at Royal Bank of Canada - MarketBeat
E-mini Nasdaq-100 Overview - CME Group
US: Market Reflections - CME Group
10-Year T-Note Futures Overview - CME Group
ALL: Market Focus - CME Group
WTI Crude Oil In FOCUS - CME Group
Japanese Yen JPY/USD Futures Overview - CME Group
The Cattle Cycle Continues - CME Group
NY Harbor ULSD Futures Overview - CME Group
The Path Ahead for Australia's Economy Intersects with Monetary Policy - CME Group
Rivals are not the only reason for CME’s lost lustre - Financial Times
Is FX Link the electronic avenue for FX swaps trading? - CME Group
CME Group Inc. (NASDAQ:CME) is favoured by institutional owners who hold 89% of the company - Simply Wall St
Corn Futures Overview - CME Group
Ameriprise Financial Inc. Buys 537,758 Shares of CME Group Inc. (NASDAQ:CME) - MarketBeat
Chicago SRW Wheat Futures Overview - CME Group
5-Year T-Note Futures Overview - CME Group
Australian Dollar AUD/USD Overview - CME Group
What’s Putting Crude Oil Prices Under Pressure? - CME Group
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Grows Stock Position in CME Group Inc. (NASDAQ:CME) - MarketBeat
US: EIA Petroleum Status Report - CME Group
Fresh from the Trading Room: Commodities comeback - CME Group
Crude Oil Futures Overview - CME Group
Interval Partners LP Sells 9,468 Shares of CME Group Inc. (NASDAQ:CME) - Defense World
Evergreen Capital Management LLC Purchases 423 Shares of CME Group Inc. (NASDAQ:CME) - Defense World
CME Group Inc. (NASDAQ:CME) Stake Increased by ProShare Advisors LLC - Defense World
MCX F&O Transaction Fee: Shareholders note! Charges revised for futures and options contracts - ET Now
MCX revises futures & options transaction charges. New rates effective from October 1 - The Economic Times
MCX revises transaction fees for futures & options after SEBI directive - CNBCTV18
MCX revises transaction fees for futures and options contracts effective Oct 1 - Business Upturn
Cme Group Inc Stock (CME) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cme Group Inc Stock (CME) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SHEPARD WILLIAM R | Director |
Sep 25 '24 |
Buy |
218.50 |
12 |
2,700 |
2,360 |
| Fitzpatrick Lynne | Sr MD Chief Financial Officer |
Sep 15 '24 |
Sale |
216.99 |
754 |
163,610 |
13,261 |
| Durkin Bryan T | Director |
Aug 30 '24 |
Sale |
214.59 |
7,593 |
1,629,382 |
55,607 |
0.23%
6.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):